miR-4759 suppresses breast cancer through immune checkpoint blockade
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-4759 suppresses breast cancer through immune checkpoint blockade
Authors
Keywords
Breast cancer, Immune checkpoint, miRNA, miR-4759, PD-L1
Journal
Computational and Structural Biotechnology Journal
Volume 20, Issue -, Pages 241-251
Publisher
Elsevier BV
Online
2021-12-17
DOI
10.1016/j.csbj.2021.12.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
- (2020) Kyle B. Lupo et al. Journal of Hematology & Oncology
- Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
- (2020) Chunxiao Li et al. Molecular Cancer
- Novel targeted therapies for metastatic breast cancer
- (2020) Khalid Jazieh et al. Annals of Translational Medicine
- CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function
- (2019) Deepak Mittal et al. Cancer Immunology Research
- Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?
- (2019) Yoshihiro Ohue et al. CANCER SCIENCE
- PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy
- (2019) Xinyi Tu et al. MOLECULAR CELL
- IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
- (2019) Li-Chuan Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- DriverDBv3: a multi-omics database for cancer driver gene research
- (2019) Shu-Hsuan Liu et al. NUCLEIC ACIDS RESEARCH
- miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database
- (2019) Hsi-Yuan Huang et al. NUCLEIC ACIDS RESEARCH
- Regulatory Mechanisms of Inhibitory Immune Checkpoint Receptors Expression
- (2019) Nicolas Curdy et al. TRENDS IN CELL BIOLOGY
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
- (2018) Jung-Mao Hsu et al. Nature Communications
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Potential regulatory roles of microRNAs and long noncoding RNAs in anticancer therapies
- (2018) Mengyan Xie et al. Molecular Therapy-Nucleic Acids
- FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
- (2018) Xiangbo Meng et al. NATURE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment
- (2018) Laura Agresta et al. Frontiers in Immunology
- Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics
- (2017) Maria A. Smolle et al. FEBS Journal
- Potential targeting of B7-H4 for the treatment of cancer
- (2017) Joseph R. Podojil et al. IMMUNOLOGICAL REVIEWS
- MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR
- (2017) Jiao Yang et al. INTERNATIONAL JOURNAL OF CANCER
- TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
- (2017) Nicholas A. Manieri et al. TRENDS IN IMMUNOLOGY
- Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells
- (2017) Masahiro Okada et al. Cell Reports
- Identification of CD112R as a novel checkpoint for human T cells
- (2016) Yuwen Zhu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- YM500v3: a database for small RNA sequencing in human cancer research
- (2016) I-Fang Chung et al. NUCLEIC ACIDS RESEARCH
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
- (2015) Jun Wei et al. NEURO-ONCOLOGY
- DriverDBv2: a database for human cancer driver gene research
- (2015) I-Fang Chung et al. NUCLEIC ACIDS RESEARCH
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
- (2015) Isabelle Le Mercier et al. Frontiers in Immunology
- HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
- (2015) Murali Janakiram et al. OncoImmunology
- Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer
- (2015) Christine Mall et al. OncoImmunology
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research
- (2014) Wei-Chung Cheng et al. NUCLEIC ACIDS RESEARCH
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
- (2013) Jan C. Dudda et al. IMMUNITY
- DriverDB: an exome sequencing database for cancer driver gene identification
- (2013) Wei-Chung Cheng et al. NUCLEIC ACIDS RESEARCH
- A Versatile Method to Design Stem-Loop Primer-Based Quantitative PCR Assays for Detecting Small Regulatory RNA Molecules
- (2013) Zsolt Czimmerer et al. PLoS One
- Expression of CD200 on AML blasts directly suppresses memory T-cell function
- (2012) S J Coles et al. LEUKEMIA
- YM500: a small RNA sequencing (smRNA-seq) database for microRNA research
- (2012) Wei-Chung Cheng et al. NUCLEIC ACIDS RESEARCH
- The role of the PD-1 pathway in autoimmunity and peripheral tolerance
- (2011) Brian T. Fife et al. Annals of the New York Academy of Sciences
- CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
- (2011) S J Coles et al. LEUKEMIA
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis
- (2009) Anna Nolan et al. PLoS One
- CD160 and BTLA: LIGHTs out for CD4+ T cells
- (2008) Jonathan Kaye NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now